Plasma osteopontin as a biomarker of Alzheimer’s disease and vascular cognitive impairment

Plasma osteopontin as a biomarker of Alzheimer’s disease and vascular cognitive impairment

Abstract Cerebrovascular disease (CeVD) and neurodegenerative dementia such as Alzheimer’s disease (AD) are frequently associated comorbidities in the elderly, sharing common risk factors and pathophysiological mechanisms including neuroinflammation. Osteopontin (OPN) is an inflammatory marker found...

Full description

Bibliographic Details
Main Authors: Yuek Ling Chai, Joyce R. Chong, Ainiah R. Raquib, Xin Xu, Saima Hilal, Narayanaswamy Venketasubramanian, Boon Yeow Tan, Alan P. Kumar, Gautam Sethi, Christopher P. Chen, Mitchell K. P. Lai
Format: Article
Language:English
Published: Nature Publishing Group 2021-02-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-83601-6

Internet

https://doi.org/10.1038/s41598-021-83601-6

Similar Items